Patent details

EP3497132 Title: REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

Basic Information

Publication number:
EP3497132
PCT Application Number:
IB2017054909
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP177688637
PCT Publication Number:
WO2018033841
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB
French Title of Invention:
RÉGIMES ET PROCÉDÉS DE TRAITEMENT DE LA SCLÉROSE EN PLAQUES À L'AIDE D'OFATUMUMAB
German Title of Invention:
THERAPIEPLÄNE UND VERFAHREN ZUR BEHANDLUNG VON MULTIPLER SKLEROSE MITTELS OFATUMUMAB
SPC Number:

Dates

Filing date:
11/08/2017
Grant date:
24/06/2020
EP Publication Date:
19/06/2019
PCT Publication Date:
22/02/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/06/2020
EP B1 Publication Date:
24/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/08/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/06/2020
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
Dennemeyer & Associates S.A.
From:
24/09/2020
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

Inventor

1

Name:
SAVELIEVA PRAZ, Marina
Address:
Switzerland (CH)

2

Name:
KAHN, Joseph Michael
Address:
United States (US)

3

Name:
KAKARIEKA WEISSKOPF, Algirdas Jonas
Address:
Switzerland (CH)

4

Name:
WALLSTRÖM, Erik
Address:
Switzerland (CH)

Priority

Priority Number:
201662374986 P
Priority Date:
15/08/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61P 25/00; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
202026
Publication date:
24/06/2020
Description:
Grant (B1)

2

Issue number:
202030
Publication date:
22/07/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/09/2025
Annual Fee Number:
9
Annual Fee Amount:
115 Euro
Expected Payer:
Last Annual Fee Payment Date:
26/07/2024
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
99 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
24/09/2020 Power Of Attorney 2
24/09/2020 Outgoing Correspondence 1